Gsk (GSK) Shareholder's Equity (2014 - 2025)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
31.20 Bn |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
81.19 Bn |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-6.66 Bn |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
45.88 Bn |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
9.19 Bn |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
23.52 Bn |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
90.10 Bn |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
20.07 Bn |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
21.78 Bn |
| Date | Value |
|---|
| Dec 31, 2025 |
21.78 Bn |
| Dec 31, 2024 |
17.55 Bn |
| Dec 31, 2023 |
16.57 Bn |
| Dec 31, 2022 |
12.43 Bn |
| Dec 31, 2021 |
20.29 Bn |
| Dec 31, 2020 |
19.26 Bn |
| Dec 31, 2019 |
14.66 Bn |
| Dec 31, 2018 |
4.87 Bn |
| Dec 31, 2017 |
4.63 Bn |
| Dec 31, 2016 |
6.17 Bn |
| Dec 31, 2015 |
13.47 Bn |
| Dec 31, 2014 |
7.82 Bn |
